Empiema necessitans y osteomielitis aguda secundaria a una infección por Staphylo-coccus aureus resistente a meticilina asociado a la comunidad

Gloria Heresi, Germán A. Contreras, Norma Pérez, James R. Murphy, Thomas G. Cleary, .

Palabras clave: empiema, osteomielitis, Staphylococcus aureus, neumonía, vancomicina.

Resumen

Staphylococcus aureus es uno de los principales patógenos a nivel mundial. Durante los últimos años se ha reportado un incremento en el número de casos de S. aureus resistente a la meticilina adquiridos en la comunidad, tanto en niños como en adultos de los Estados Unidos y de otras partes del mundo.
En el presente trabajo reportamos un caso de empiema necessitans y osteomielitis aguda en un niño de 19 meses de edad previamente sano. El presente reporte resalta la cambiante epidemiología de S. aureus tanto en la comunidad como en el medio hospitalario y la importancia de establecer guías apropiadas para el diagnóstico, el tratamiento y la vigilancia de este relevante problema de salud pública.

Descargas

La descarga de datos todavía no está disponible.
  • Gloria Heresi Division of Pediatrics Infectious Diseases, Department of Pediatrics, University of Texas Medical School at Houston, Houston, TX, USA.
  • Germán A. Contreras Division of Pediatrics Infectious Diseases, Department of Pediatrics, University of Texas Medical School at Houston, Houston, TX, USA Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogotá, D.C., Colombia
  • Norma Pérez Division of Pediatrics Infectious Diseases, Department of Pediatrics, University of Texas Medical School at Houston, Houston, TX, USA.
  • James R. Murphy Division of Pediatrics Infectious Diseases, Department of Pediatrics, University of Texas Medical School at Houston, Houston, TX, USA.
  • Thomas G. Cleary Division of Pediatrics Infectious Diseases, Department of Pediatrics, University of Texas Medical School at Houston, Houston, TX, USA.

Citas

1. Mizell KN, Patterson KV, Carter JE. Empyema necessitatis due to methicillin-resistant Staphylococcus aureus: case report and review of the literature. J Clin Microbiol. 2008;46:3534-6.
2. Freeman AF, Ben-Ami T, Schulman ST. Streptococcus pneumonia empyema necessitatis. Infect Dis J. 2004;23:177-8.
3. Ahmed SI, Gripaldo RE, Alao OA. Empyema necessitans in the setting of pneumonia and parapneumonic effusion. Am J Med Sci. 2007;333:106-8.
4. Denlinger CE, Egan TM, Jones DR. Acquired systemic-to-pulmonary arteriovenous malformation secondary to Mycobacterium tuberculosis empyema. Ann Thorac Surg. 2002;74:1229-31.
5. Stallworth J, Mack E, Ozimek C. Methicillin-resistant Staphylococcus aureus empyema necessitatis in an eight-month-old child. South Med J. 2005;98:1130-1.
6. Moore FO, Berne JD, McGovern TM, Ravishankar S, Slamon NB, Hertzog JH. Empyema necessitatis in an infant: a rare surgical disease. J Pediatr Surg. 2006;41:e5-7.
7. Chen CJ, Huang YC, Chiu CH, Su LH, Lin TY. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis J. 2005;24:40-5.
8. Ma XX, Galiana A, Pedreira W, Mowszowicz M, Christophersen I, Machiavello S, et al. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis. 2005;11:973-6.
9. Bratu S, Eramo A, Kopec R, Coughlin E, Ghitan M, Yost R, et al. Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis. 2005;11:808-13.
10. Alfaro C, Fergie J, Purcell K. Emergence of community-acquired methicillin-resistant Staphylococcus aureus in complicated parapneumonic effusions. Pediatr Infect Dis J. 2005;24:274-6.
11. Gonzalez BE, Hulten KG, Dishop MK, Lamberth LB, Hammerman WA, Mason EO Jr, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005;41:583-90.
12. Musher DM, Lamm N, Darouiche RO, Young EJ, Hamill RJ, Landon GC, et al. The current spectrum of Staphylococcus aureus infection in a tertiary care hospital. Medicine (Baltimore).1994;73:186-208.
13. Lesens O, Hansmann Y, Brannigan E, Remy V, Hopkins S, Martinot M, et al. Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteremia. J Infect. 2004;48:245-52.
14. Abraham J, Mansour C, Veledar E, Khan B, Lerakis S. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S. aureus and methicillin-resistant S. aureus bacteremia. Am Heart J. 2004;147:536-9.
15. Valente AM, Jain R, Scheurer M, Fowler VG Jr, Corey GR, Bengur AR, et al. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics. 2005;115:e15-9.
16. Grayson ML. The treatment triangle for staphylococcal infections. N Engl J Med. 2006;355:724-7.
17. Le J, Lieberman JM. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy. 2006;26:1758-70.
18. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylo-coccus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003;37:1257-60.
19. Adra M, Lawrence KR. Trimethoprim-sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother. 2004;38:338-41.
20. Dumitrescu O, Badiou C, Bes M, Reverdy ME, Vandenesch F, Etienne J, et al. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect. 2008;14:384-8.
21. Chambers HF. The changing epidemiology of Staphylo-coccus aureus? Emerg Infect Dis. 2001;7:178-82.
22. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistantStaphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-44.
23. Alvarez CA, Barrientes OJ, Leal AL, Contreras GA, Barrero L, Rincón S, et al. Community-associated methicillin-resistant Staphylococcus aureus, Colombia. Emerg Infect Dis. 2006;12:2000-1.
24. Ochoa TJ, Mohr J, Wanger A, Murphy JR, Heresi GP. Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerg Infect Dis. 2005;11:966-8.
25. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-27.
26. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006;367:731-9.
27. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med. 2007;13:1510-4.
28. Hanssen AM, Ericson Sollid JU. SCCmec in staphylococci: genes on the move. FEMS Immunol Med Microbiol. 2006;46:8-20.
29. Nicolle L. Community-acquired MRSA: a practitioner’s guide. CMAJ. 2006;175:145.
30. Kaplan SL. Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis. 2006;17:113-9.
Cómo citar
Heresi, G., Contreras, G. A., Pérez, N., Murphy, J. R., & Cleary, T. G. (2009). Empiema necessitans y osteomielitis aguda secundaria a una infección por Staphylo-coccus aureus resistente a meticilina asociado a la comunidad. Biomédica, 29(4), 506-12. https://doi.org/10.7705/biomedica.v29i4.124

Más sobre este tema

Publicado
2009-12-01
Sección
Presentación de caso